Excerpt from a Florida Hospital story about Ifenprofil."But there is hope. Westchester is among a few hospitals around the world studying a new drug. Dr. Jose Suarez: So were doing a trial with Algernon, a medication called Ifenprodil, which has been around since the 70s, and were starting to use it on COVID patients, and its a potent anti-inflammatory. Its hoped the drug will reduce the scarring of lung tissue which has led to so many long term problems. Right now, its only being used on critically ill patients, and Dr. Suarez says the results are looking good. Dr. Jose Suarez: These patients are not getting that scarring that we usually see with the COVID patients, and their reactions to the treatment is phenomenal. Dr. Suarez says 10 patients who have received the drug have recovered from COVID without the scarring, and he believes studies like this one provide hope for future COVID patients". Full Stop What we were told by the CEO is it was too expensive to retrieve the X-ray data for all the patients who participated in the study. We were left dangling with the IDEA that we were onto some miracle drug results. Results without the data to back it up. We ultimately know what happened, and to this day do not know if management ever got a look at any of those X-rays for 200+ patients. Just left it all on the table. Does that make any sense? Overhype Under Deliver. End of story.